Access cutting-edge cannabinoid hyperemesis syndrome treatment through this phase 3 clinical trial at a research site in Toledo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Toledo location
Preparing your pre-screening questions…
Access cannabinoid hyperemesis syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cannabinoid hyperemesis syndrome treatment provided free
Check if you qualify for this cannabinoid hyperemesis syndrome clinical trial in Toledo, OH
No-Cost Study Care
Local to Toledo
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals of 0.5.
Sponsor: Mercy Bon Secours Saint Vincent Medical Center
Yes, this clinical trial (NCT07246187) has an active research site in Toledo, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cannabinoid hyperemesis syndrome treatment options in Toledo, OH, this clinical trial (NCT07246187) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Toledo research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced cannabinoid hyperemesis syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cannabinoid hyperemesis syndrome clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Toledo — not just this study.
Browse Pulmonary Embolism Trials in Toledo →